FORM SC 13D

Company

Altimmune, Inc.

Filed

August 12, 2013

Accession Number

0001144204-13-044795

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →